Stevens–Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer

M. Urosevic-Maiwald,T. Harr,L. French,R. Dummer
DOI: https://doi.org/10.1111/j.1365-4632.2011.05356.x
2012-07-01
International Journal of Dermatology
Abstract:Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life‐threatening adverse drug reactions. Herein we report about a patient with head and neck cancer, who developed SJS‐TEN overlap after having received cetuximab and radiotherapy. To date, there are only two reports of TEN associated with cetuximab therapy in patients with cancer. Every skin condition in a patient with cancer leading to extensive exfoliation of the skin should alert the oncologist of a possibility of drug‐induced SJS or TEN.
What problem does this paper attempt to address?